SCHEMBL25925911

SCHEMBL25925911

Cn1nccc1/N=N/c1ccc(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.49
MAPT P10636 6/20 0.47
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
POLB P06746 3/20 0.47
MAPK1 P28482 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
KDM4E B2RXH2 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
IDO1 P14902 1/20 0.47
TDO2 P48775 1/20 0.47
GFER P55789 1/20 0.47
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
NSD2 O96028 2/20 0.37
MMP14 P50281 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925862 0.87 MAPT (0.34) EGFRMAPTMEN1KMT2APOLB
SCHEMBL25926077 0.85 TSHR (0.36) EGFRMAPTMEN1KMT2APOLB
SCHEMBL25926069 0.82 KCNH2 (0.54) EGFRMAPTMEN1KMT2APOLB
SCHEMBL25925932 0.81 ESR1 (0.33) MAPTMEN1KMT2ATDP1ALDH1A1
SCHEMBL25925882 0.77 AHR (0.36) EGFRMAPTMEN1KMT2AMAPK1
SCHEMBL25925704 0.77 MAPT (0.33) MAPTMEN1KMT2AMAPK1NPSR1
SCHEMBL25925941 0.77 KCNH2 (0.34) KCNH2
SCHEMBL25925733 0.74 ALDH1A1 (0.36) MAPTALDH1A1
SCHEMBL25925933 0.73 PTGS1 (0.41) MAPTMEN1KMT2AMAPK1KDM4E
SCHEMBL25925873 0.73 RAB9A (0.36) MAPTMEN1KMT2APOLBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 EGFR 3913/4885MAPT 2/4885MEN1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.